U.S. top court says extracted human DNA cannot be patented
WASHINGTON, June 13
WASHINGTON, June 13 (Reuters) - The U.S. Supreme Court on Thursday issued a mixed ruling in a case concerning patents held by Myriad Genetics Inc over the closely watched issue of whether human genes can be patented.
In a unanimous vote, the nine justices reached a compromise by saying synthetically produced genetic material can be patented but that genes extracted from the human body, known as isolated DNA, do not merit the same legal protections.
- Special Report: Thailand secretly supplies Myanmar refugees to trafficking rings |
- UPDATE 1-China central bank warns banks against use of bitcoin
- The 10 Most Corrupt and Least Corrupt Countries in the World
- China central bank warns banks against use of bitcoin
- Obama says he's not allowed iPhone for 'security reasons'